Modification of the gut microbiome to combat neurodegeneration

被引:31
作者
Sasmita, Andrew Octavian [1 ]
机构
[1] Georg August Univ Gottingen, Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Grisebachstr, D-537077 Gottingen, Germany
关键词
dysbiosis; gut-brain axis; gut microbiome; neurodegenerative diseases; probiotics; psychobiotics; AMYOTROPHIC-LATERAL-SCLEROSIS; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; L-DOPA; HELICOBACTER-PYLORI; DOUBLE-BLIND; FATTY-ACIDS; MODEL; DYSFUNCTION; DYSBIOSIS;
D O I
10.1515/revneuro-2019-0005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The gut microbiome was extensively researched for its biological variety and its potential role in propagating diseases outside of the gastrointestinal (GI) tract. Recently, a lot of effort was focused on comprehending the gut-brain axis and the bizarre communication between the GI system and the nervous system. Ample amount of studies being carried out also revealed the involvement of the gut microbiome in enhancing the degree of many neurological disorders, including neurodegenerative diseases. It was widely observed that there were distinct microbiome profiles and dysbiosis within patients-suffering from Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Various approaches to re-establish the balance of the gut microbiome, from antibiotic therapy, fecal microbiota transplant, or ingestion of psychobiotics, are discussed within this review within the specific context of combating-neurodegenerative diseases. Present studies and clinical trials indicate that although there is an immense potential of gut microbiome modification to be preventive or therapeutic, there are still many intercalated components of the gut-brain axis at play and thus, more research needs to be carried out to delineate microbiome factors that may potentially alleviate symptoms of neurodegeneration.
引用
收藏
页码:795 / 805
页数:11
相关论文
共 50 条
  • [31] Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms
    Shi, Zhuangzhuang
    Zhang, Mingzhi
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [32] Gut microbiome and kidney disease: a bidirectional relationship
    Al Khodor, Souhaila
    Shatat, Ibrahim F.
    PEDIATRIC NEPHROLOGY, 2017, 32 (06) : 921 - 931
  • [33] Restoration of dysbiotic human gut microbiome for homeostasis
    Dixit, Kunal
    Chaudhari, Diptaraj
    Dhotre, Dhiraj
    Shouche, Yogesh
    Saroj, Sunil
    LIFE SCIENCES, 2021, 278
  • [34] Current Perspectives on Gut Microbiome Dysbiosis and Depression
    Capuco, Alexander
    Urits, Ivan
    Hasoon, Jamal
    Chun, Rebecca
    Gerald, Brittany
    Wang, Jason K.
    Kassem, Hisham
    Ngo, Anh L.
    Abd-Elsayed, Alaa
    Simopoulos, Thomas
    Kaye, Alan D.
    Viswanath, Omar
    ADVANCES IN THERAPY, 2020, 37 (04) : 1328 - 1346
  • [35] Gut microbiome and nonalcoholic fatty liver disease
    Wu, Meng -Yuan
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 444 - 451
  • [36] A Review of the Relationship between Gut Microbiome and Obesity
    Zsalig, Dorottya
    Berta, Aniko
    Toth, Vivien
    Szabo, Zoltan
    Simon, Klara
    Figler, Maria
    Pusztafalvi, Henriette
    Polyak, Eva
    APPLIED SCIENCES-BASEL, 2023, 13 (01):
  • [37] The Gut Microbiome: a New Frontier in Musculoskeletal Research
    Li, R.
    Boer, C. G.
    Oei, L.
    Medina-Gomez, Carolina
    CURRENT OSTEOPOROSIS REPORTS, 2021, 19 (03) : 347 - 357
  • [38] Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
    Elzayat, Hala
    Mesto, Ghaidaa
    Al-Marzooq, Farah
    NUTRIENTS, 2023, 15 (15)
  • [39] Gut Microbiome: Implications on gut Health.
    Nagaraja, T. G.
    JOURNAL OF ANIMAL SCIENCE, 2022, 100 : 45 - 45
  • [40] The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”
    Anne-Katrin Pröbstel
    Sergio E. Baranzini
    Neurotherapeutics, 2018, 15 : 126 - 134